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Marine-Derived n-3 FAs Protect Against Atherosclerosis
Sekikawa and colleagues performed electron beam computed tomography andcarotid intima-media thicknessmeasurements onmen age 40 to49 yearswhowere
Japanese,whiteAmericans, and JapaneseAmericans.Thefindingswere then compared
with traditional cardiac risk factors as well as with serum levels of marine-derived n-3
fatty acids (FAs). Japanese men had the lowest levels of atherosclerosis as well as the
highest levels of FAs. The differences in severity of atherosclerosis between groups
became nonsignificant after adjusting for the level of FAs. These data suggest that high
serum levels of marine-derived n-3 FAs have antiatherogenic properties. See pages
417 and 425.
Page 430
Heart Failure
Hospitalizations for HF Doubled Over the Past 25 Years
Fang and colleagues used the National Hospital Discharge Survey data to studytrends in hospitalizations for heart failure (HF) in the U.S. over the past 26 years.
The overall number of hospitalizations withHF listed as the primary or a contributing
diagnosis tripled over this period, which amounts to a doubling when corrected for the
increased population. There were especially significant increases in the number of
hospitalizations for patients age85 years and in the frequency with which patients
were discharged to long-term care facilities. These findings highlight the increasing
prevalence of HF and its role as a source of increased financial demands for Medicare.
See pages 428 and 435. See figure.
Heart Failure
Identifying Factors That Affect Mortality in Candidates for CRT
Cleland and colleagues analyzed both baseline variables and early responsemarkersto identify which would better predict the impact of cardiac resynchronization
therapy (CRT) on long-term mortality. The strongest predictors of mortality were
serum levels of amino terminal pro-brain natriuretic peptide (NT-proBNP) and the
severity of mitral regurgitation at 3 months, regardless of assignation to CRT or
control. Patients who have refractory mitral regurgitation or elevated NT-proBNP
despite treatments for heart failure, including CRT, have higher mortality. However,
the effect of CRT on mortality cannot be predicted from these baseline or early
response markers. See page 438.
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Biomarkers
Troponin and NT-proBNP Levels Predict Mortality in Older Adults
Daniels and colleagues investigated the prognostic value of cardiac troponin T(TnT) andN-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in a
population of community-dwelling, older (mean age 77 years) adults who were
followed for up to 9 years. The 4%of participants with detectable TnT (0.01 ng/ml)
were approximately twice as likely to die. Elevated NT-proBNP (450 pg/ml) was
found in approximately 20% of subjects and also predicted increased mortality. The
levels of TnT andNT-proBNPwere influenced by several comorbidities including age
and renal function, but remained significant inmultivariablemodels.Older adultswith
detectableTnTor elevatedNT-proBNP levels are at increased risk of death.Seepage
450. See figure.
Congenital Heart Disease
Functional Status After Operation for Ebstein Anomaly
Ebstein anomaly is a spectrum of tricuspid valvular and right ventricular dysplasiaswith variable severity. Brown and colleagues contacted almost 300 patients who
had undergone surgical repair for an Ebstein anomaly over the past 30 years. Eighty-
three percent of patients who were alive were in New York Heart Association func-
tional class I or II and 34%were taking no cardiacmedications. Thirty-six percent had
experienced an atrial arrhythmia. Patients have good long-term survival and functional
outcomes after operation for Ebstein anomaly; techniques to reduce the frequency of
atrial arrhythmias should be considered. See pages 460 and 467.
Page 489
Preclinical Research
New MRI Method Can Image Macrophages in Atherosclerotic Plaque
Thepurpose of this studywas to usemagnetic resonance imaging (MRI) to identifymacrophage-rich atherosclerotic plaque noninvasively. Hyperlipidemic rabbits
were injected with iron oxide nanoparticles and then imaged using a positive contrast
off-resonance imaging sequence. After administration of the particles, signal enhance-
ment was found only in hyperlipidemic rabbits, and the magnitude of the enhance-
ment correlatedwith the number ofmacrophages determined by histology. An accom-
panying editorial explains how this technique improves on previous MRI and notes
that the iron particles are commercially available and appear to be safe in humans.
See pages 483 and 492. See figure.
